Learn about the proceedings that state insurance regulators may bring against insurers for violating provisions of a state insurance code or administrative regulations. Read now » Related Content Creating and Maintaining Good Relationships...

Two U.S. senators have revived a longstanding legislative proposal that would expand digital privacy protections to cover teens between the ages of 13 and 16, ban targeted advertising to minors, and require companies to enable the erasure of underage...

Do you need to stay up to date with key legal developments in Artificial Intelligence (AI) litigation, including labor and employment claims involving AI? Review and set an alert on the Artificial Intelligence: Federal Litigation Tracker . Read now...

Discover essential best practices for maintaining ethical standards when collaborating with vendors in litigation. Our latest checklist guides you through identifying tasks where vendors can enhance your practice, understanding the relevant Model Rules...

Since its founding in 1997, the international consultancy BLJ Worldwide has maintained a strong focus on delivering actionable media intelligence to its clients. As the media landscape evolved—reshaped by round-the-clock coverage and the viral nature...

Erfahren Sie, wie unser mehrfach ausgezeichnetes Medienbeobachtungs-Tool Nexis Newsdesk funktioniert und welche Möglichkeiten die Medienbeobachtung für Ihr Unternehmen bietet. Im Rahmen einer Online-Demo demonstrieren wir Ihnen, wie Sie mit...

The new and upgraded Nexis Uni was released in October 2024. Learn more about the new look and feel as well as new features including.

Das neue und verbesserte Nexis Uni ist seit Oktober 2024 live. Mehr über das neue Look & Feel sowie neue Funktionen erfahren Sie in unserem Webinar.

This state law survey covers key issues related to operating wholesale drug distributors in the 50 U.S. states and District of Columbia, including products regulated, licensing requirements, and designated representative requirements. Read now »...

Understand preemptive steps for maximizing a pharmaceutical product's regulatory and patent exclusivities and the chances of success in future patent litigation against generic drug applicants. Read now » Related Content Life Sciences...